Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Citizens & Northern Corp. (CZNC)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
$28.25-1.09%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.75 → 2.75 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CZNC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
5 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain quarterly dividends at $0.28 per share | Citizens & Northern keeps paying steady dividends of $0.28 per share. | Intact | dividend falls below $0.28 per share in any quarter | Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking recovery and execution story, not a clear durable compounder today. Management is making progress on earnings and efficiency, while credit results and loan balances remain mixed; the current thesis state is watch.
CZNC is expensive versus peers, though the valuation and expectations are broadly aligned and the priced-in assessment is tagged justified. The expectations gap is slightly negative, and valuation has fallen notably in the recent period, so the evidence does not point to a large cushion if execution disappoints.
Near term, earnings delivery is uncertain: the latest quarter was a miss, recent surprises have been erratic, and the evidence flags guidance cuts as a meaningful risk. Over the multi-year view, higher quarterly net income and better operating efficiency are constructive, but recent total loan balances declined and year-to-date credit losses remain substantial despite lower nonperforming assets.
The thesis depends on profitable loan growth, continued progress resolving problem loans, and earnings improvements that are not mainly driven by the Susquehanna acquisition. Near-term results could weaken if guidance is cut or rates begin falling; continued strength from financial-sector peers would be a favorable signal for the sector backdrop.
For the next 1 to 3 years, CZNC has credible operational progress but uneven credit and loan trends, a recent earnings miss, and an expensive peer-relative valuation. The long-term thesis remains watchful and depends on consistent execution. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Citizens & Northern Corp.'s published investment case. The stated target is >=1.85 USD for 2025, >=1.97 USD for 2026. |
| Broken |
| EPS falls below $1.85 in 2025 or below $1.97 in 2026 |
Diluted EPS: $0.79 per share FY2026-Q2; GAAP. Published target: >=1.85 USD for 2025, >=1.97 USD for 2026. Target period ends 2025-12-31 and 2026-12-31; this observation covers 2026-Q2. Aug 7, 20260.79 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Smooth transition of key executives without disruption | A supporting condition in Citizens & Northern Corp.'s published investment case. The stated target is No major operational disruption from retirements in 2026. | Improving | Significant disruption or loss of key executives harms operations | 1 executive retirement (Kelley Cwiklinski) effective 2026-07-10; no reported operational disruption Kelley Cwiklinski retired July 10, 2026. No news of operational disruption or further key executive losses reported. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating income above $335,000 per quarter | Cash flow stays positive, above $1.5 million each quarter. | Intact | operating income falls below $335,000 next quarter | Operating income: $-335,000 FY2026-Q2; GAAP. Published target: >=335,000 USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 7, 2026-335,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain positive cash flow from operations above $1.5 million | Cash flow stays positive, above $1.5 million each quarter. | Intact | cash flow from operations falls below $1.5 million in any quarter | Cash from operations: $15.424M FY2026-Q2; GAAP. Published target: >=1.5 million USD. Target period is not explicitly aligned with this observation. Aug 7, 202615,424,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.70 → $2.75 · observed estimates
$0.15B → $0.15B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-25 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-26 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-27 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-28 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-29 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-30 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-07-31 | $2.70 | Unavailable | 1 / 0 |
| 2026-08-01 | $2.70 | $154,200,000 | 1 / 1 |
| 2026-08-02 | $2.75 | Unavailable | 1 / 0 |
| 2026-08-03 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-04 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-05 | $2.75 | Unavailable | 1 / 0 |
| 2026-08-06 | $2.75 | Unavailable | 1 / 0 |
| 2026-08-07 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-08 | $2.75 | Unavailable | 1 / 0 |
| 2026-08-09 | $2.75 | Unavailable | 1 / 0 |
| 2026-08-10 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-11 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-12 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-13 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-14 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-15 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-16 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-17 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-18 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-19 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-20 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-21 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-22 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-23 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-24 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-25 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-26 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-27 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-28 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-29 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-30 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-08-31 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-01 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-02 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-03 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-04 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-05 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-06 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-07 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-08 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-09 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-10 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-11 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-12 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-13 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-14 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-15 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-16 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-17 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-18 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-19 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-20 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-21 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-22 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-23 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-24 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-25 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-26 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-27 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-28 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-29 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-09-30 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-01 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-02 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-03 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-04 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-05 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-06 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-07 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-08 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-09 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-10 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-11 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-12 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-13 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-14 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-15 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-16 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-17 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-18 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-19 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-20 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-21 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-22 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-23 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-24 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-25 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-26 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-27 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-28 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-29 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-30 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-10-31 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-11-01 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-11-02 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-11-03 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-11-04 | $2.75 | $154,200,000 | 1 / 1 |
| 2026-11-05 | $2.75 | $154,200,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 5 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.